The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Gilead Sciences Inc (GILD)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
A More Focused Highly Defensive Index

Dec 03, 2008 01:33 AM GMT
Mikerun
Return Risk
+1.04% LOW
Principal

A More Focused Highly Defensive Index


The accompanying table [click to enlarge] includes an updated version of the ETF Innovators [ETFI] ETFI Highly Defensive PerformIdex of 36 companies based in the U.S., Canada, and Europe with market caps over $10B, which are the leaders by market cap in their defensive industry groups. This update includes a 10% reduction in the number of companies with an equal distribution of 12 each from consumer staples and healthcare, with the remaining 12 companies chosen from a variety of defensive industry groups.

(A) Mass Merchant Discount Retailer (1)
(B) Consumer Staples (12) – Non-Food/Beverage (2), Processed & Packaged Foods (3), Tobacco (2) (1 U.S. + 1 ex-U.S.), Alcoholic Beverages (1), Non-Alcoholic Beverages (2), Diversified Products (2)
(C) Telecom Services (4)
(D) Cable Television & Internet Access Providers (1)
(E) Utilities (2)
(F) Fast Food Restaurants (1)
(G) Commodities (2): Gold Mining (1) + Agri-Biotech (Seeds & Fertilizers) (1)
(H) Healthcare (12) – Top Seven Companies by Market Cap (7), Biotech (3) Medical Devices (excluding stents) (1), Generic Drugs (1)
(I) Aerospace (Non-Commercial) & Defense (1)

Over the past year, the index has outpaced its benchmark ETFs on a total return basis with a loss of 16.6%, including the Sabrient/Claymore Defensive ETF (DEF) (-34.6%), Consumer Staples Sector SPDR (XLP) (-18.3%), Healthcare Sector SPDR (XLV) (-31.3%), Utilities Sector SPDR (XLU) (-27.1%), Dow Jones Global Titans (DGT) (-39.7%), and the iShares Dow Jones Select Dividend (DVY) (-35.7%). Also, the equally-weighted defensive index is only 59% as volatile as the overall market with an average market cap of nearly $75B and above-market dividend yield of 3.4%, with a diversified mix of companies and industry groups chosen to outpace benchmark ETFs which focus on a single theme such as dividends, healthcare, or consumer staples.

Among the 36 component companies, I believe Altria Group (MO) and Pfizer (PFE) are defensive dividend, value buys at current levels as each company currently pays a dividend of $1.28 per share annually – resulting in bloated yields of 8.5% and 8%, respectively. Four companies in the index have posted gains on a total return basis (stock price change + dividend yield) over the past year despite unprecedented volatility and major market declines – including a diversified mix of Wal-Mart (WMT), General Mills (GIS), McDonalds (MCD), and Southern Company (SO).

In the healthcare sector, several companies have posted single-digit share price declines over the past year, demonstrating relative strength compared to major losses in the overall market and healthcare sector – including Amgen (AMGN), Genentech (DNA), Gilead Sciences (GILD), Abbott Labs (ABT), and Teva Pharma (TEVA). Among telecom services, AT&T (T), Verizon (VZ), Vodafone (VOD), and Telefonica (TEF) have an average dividend yield over 6%, but this was offset by an average stock price decline of nearly one-third.

Click here for links to my previous articles on defensive investing strategies and indexes or related topics on dividends and healthcare .


GILD:  This call was made on 12/03/08 @ $43.67
Rating:   Positive   $43.67 (12/03/08)
Closed:   02/22/2009 @ $50.1 (+14.72% in 80 days)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.75% 378
2 18.14 +69.56% 208
3 17.66 +25.70% 55
4 13.47 +14.32% 61
5 12.13 +75.10% 38


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Gilead Sciences Inc (GILD)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
90.5%
Top:
66.5%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
NVO Positive +0.00% 11/22/09
DNDN Positive +0.25% 11/20/09
UNIFF N/A Positive n/a 11/19/09
BIO Positive -1.61% 11/19/09
ECTE N/A Positive n/a 11/19/09

View All >
   
Mike Havrilla previously rated GILD
Positive -2.28% FDA Calendar Updates: SNTS, CEPH, AZN, DNDN, GILD, NVO
04/06/2009
9
Positive +7.84% Updated Clinical Trial and FDA Decision Calendars
02/28/2009
9
Positive -11.62% New Index of Highly Defensive Market Cap Leaders
02/25/2009
9
Positive -0.58% Updated Clinical Trial and FDA Decision Calendars
02/22/2009
9
Positive +0.18% Achillion Pharma: Funding in Place to Advance HCV Pipeline
11/25/2008
9





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch